These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 6021942)

  • 21. [Molecular diffusion/cerebrospinal fluid flow theory].
    Dorta-Contreras AJ; Reiber H
    Rev Neurol; 2004 Sep 16-30; 39(6):564-9. PubMed ID: 15467996
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Challenges for blood-brain barrier (BBB) screening.
    Jeffrey P; Summerfield SG
    Xenobiotica; 2007; 37(10-11):1135-51. PubMed ID: 17968740
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Usefulness and limitation of primary cultured porcine choroid plexus epithelial cells as an in vitro model to study drug transport at the blood-CSF barrier.
    Angelow S; Zeni P; Galla HJ
    Adv Drug Deliv Rev; 2004 Oct; 56(12):1859-73. PubMed ID: 15381337
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Symposium on membrane transport. Transport aspects of bile secretion.
    Lathe GH
    Proc R Soc Med; 1967 Apr; 60(4):335-6. PubMed ID: 6021658
    [No Abstract]   [Full Text] [Related]  

  • 25. [Astroglia. Structure, stereological and functional relations to extracellular space of central nervous system ].
    Wagner HJ; Pilgrim C
    Dtsch Med Wochenschr; 1979 Feb; 104(5):187-90. PubMed ID: 32024
    [No Abstract]   [Full Text] [Related]  

  • 26. A new in vitro model for blood-cerebrospinal fluid barrier transport studies: an immortalized choroid plexus epithelial cell line derived from the tsA58 SV40 large T-antigen gene transgenic rat.
    Hosoya K; Hori S; Ohtsuki S; Terasaki T
    Adv Drug Deliv Rev; 2004 Oct; 56(12):1875-85. PubMed ID: 15381338
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Delivery of therapeutic agents to the central nervous system: the problems and the possibilities.
    Begley DJ
    Pharmacol Ther; 2004 Oct; 104(1):29-45. PubMed ID: 15500907
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Applications of a blood-brain barrier technology platform to predict CNS penetration of various chemotherapeutic agents. 1. Anti-infective drugs.
    Adenot M; Perriere N; Scherrmann JM; Lahana R
    Chemotherapy; 2007; 53(1):70-2. PubMed ID: 17202814
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Adrenomedullin in the central nervous system].
    Ueta Y
    Nihon Rinsho; 2004 Sep; 62 Suppl 9():246-51. PubMed ID: 15506379
    [No Abstract]   [Full Text] [Related]  

  • 30. Brain barrier phenomena.
    Levin E; Scicli G
    Brain Res; 1969 Mar; 13(1):1-12. PubMed ID: 4896648
    [No Abstract]   [Full Text] [Related]  

  • 31. [Blood brain barrier: development of a structure which supports the functional heterogeneity of the central nervous system].
    Pascual Garvi JM; González Llanos F; Prieto Arribas R; Cerdán S; Roda JM
    Rev Neurol; 2004 Mar 16-31; 38(6):565-81. PubMed ID: 15054722
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immune surveillance of the human central nervous system (CNS): different migration pathways of immune cells through the blood-brain barrier and blood-cerebrospinal fluid barrier in healthy persons.
    Kleine TO; Benes L
    Cytometry A; 2006 Mar; 69(3):147-51. PubMed ID: 16479603
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Extracellular potassium in the mammalian central nervous system.
    Somjen GG
    Annu Rev Physiol; 1979; 41():159-77. PubMed ID: 373587
    [No Abstract]   [Full Text] [Related]  

  • 34. A STUDY OF THE BLOOD-CEREBROSPINAL FLUID-CENTRAL NERVOUS SYSTEM BARRIER IN MULTIPLE SCLEROSIS. II. A POSSIBLE MODEL STUDY FOR OTHER DISEASES.
    TOURTELLOTTE WW; HAERER AF; PARKER JA
    Rev Neuropsiquiatr; 1964 Sep; 27():260-76. PubMed ID: 14333869
    [No Abstract]   [Full Text] [Related]  

  • 35. Blood-brain barrier permeability considerations for CNS-targeted compound library design.
    Hitchcock SA
    Curr Opin Chem Biol; 2008 Jun; 12(3):318-23. PubMed ID: 18435937
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Model for transport in the central nervous system.
    Spector R; Spector AZ; Snodgrass SR
    Am J Physiol; 1977 Mar; 232(3):R73-9. PubMed ID: 842696
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Active transport of high-affinity choline and nicotine analogs into the central nervous system by the blood-brain barrier choline transporter.
    Allen DD; Lockman PR; Roder KE; Dwoskin LP; Crooks PA
    J Pharmacol Exp Ther; 2003 Mar; 304(3):1268-74. PubMed ID: 12604705
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Supravital staining experiments concerning the problem of metabolism in the CNS of the rat, especially in the hypothalamus and infundibulum].
    Eberhardt HG
    Z Mikrosk Anat Forsch; 1971; 83(4):525-34. PubMed ID: 5121520
    [No Abstract]   [Full Text] [Related]  

  • 39. The blood-brain barrier and blood-cerebral spinal fluid barrier.
    Moody DM
    Semin Cardiothorac Vasc Anesth; 2006 Jun; 10(2):128-31. PubMed ID: 16959739
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Elevated expression of glucose transporter-1 in hypothalamic ependymal cells not involved in the formation of the brain-cerebrospinal fluid barrier.
    Garcia MA; Carrasco M; Godoy A; Reinicke K; Montecinos VP; Aguayo LG; Tapia JC; Vera JC; Nualart F
    J Cell Biochem; 2001; 80(4):491-503. PubMed ID: 11169733
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.